Checkpoint Inhibitor Therapy (CIT)
Checkpoint inhibitor therapy (CIT) is a form of cancer immunotherapy that targets immune checkpoints, key regulators of the immune system. By blocking these checkpoints, CIT enhances the immune response against cancer
Read More